AI In Oncology Market Size, Share Report & Forecast, 2033

AI In Oncology Market Report by Component (Software Solutions, Hardware, Services), Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, and Others), Treatment Type (Chemotherapy, Radiotherapy, Immunotherapy, and Others), Application (Cancer Detection, Drug Discovery, Drug Development, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A12484

Buy Now New Year Sale

Market Overview:

The global AI In oncology market size reached USD 1,542.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 18,253.8 Million by 2033, exhibiting a growth rate (CAGR) of 30.01% during 2025-2033. The escalating prevalence of cancer, rising awareness among the masses regarding early diagnosis of cancer, and the introduction of AI-based clinical decision support system represent some of the key factors driving the market.

Report Attribute	Key Statistics
Base Year	2024
Forecast Years	2025-2033
Historical Years	2019-2024
Market Size in 2024	USD 1,542.9 Million
Market Forecast in 2033	USD 18,253.8 Million
Market Growth Rate (2025-2033)	30.01%

Artificial intelligence (AI) in oncology refers to the use of algorithms and technology in cancer research and treatment. It has revolutionized the field of oncology by facilitating early detection of cancer, developing precision medicine, enabling drug discovery, and designing personalized treatment plans. AI in oncology is widely used to treat breast, ovarian, lung, prostate, colorectal, skin, leukaemia, and brain cancers. It aids in analyzing large volumes of data quickly, identifying patterns, improving treatment accuracy, and reducing the risk of misdiagnosis and delayed detection. AI in oncology can also inspect results from mammograms, computed tomography (CT) scans, and pathology slides to identify potentially cancerous lesions and assist radiologists and pathologists in making accurate diagnoses. It also provides data-driven insights into electronic health records, genomics data, and clinical trials, which aids in discovering new biomarkers and improving the understanding of cancer biology.

AI In Oncology Market Trends:

The escalating prevalence of cancer across the globe due to genetics and unhealthy lifestyle is one of the primary factors propelling the market growth. AI in oncology is widely used in chemotherapy, radiotherapy, immunotherapy, and other treatments to predict outcomes, optimize parameters, select the most suitable therapy option, and assist healthcare professionals in making informed decisions. In addition to this, the widespread technology utilization to predict the likelihood of disease progression, recurrence, and overall survival rate of patients is acting as another growth-inducing factor. Furthermore, the rising awareness among the masses regarding early detection and diagnosis of cancer to enable quick intervention and prevent future complications is providing an impetus to the market growth. Additionally, the introduction of AI-based clinical decision support systems, which aids oncologists in analyzing patient-specific data, such as clinical records, imaging data, and molecular profiles, to select appropriate therapies, predict treatment outcomes, and manage potential side effects, is positively influencing the market growth. Moreover, the acute shortages of healthcare professionals in the field of oncology are facilitating the demand for AI-based solutions to provide accurate and efficient treatment and diagnosis. Apart from this, the implementation of supportive government policies to spread awareness regarding cancers and their treatments and provide access to high-quality healthcare facilities is contributing to the market growth. Other factors, including the growing healthcare expenditure, increasing investment by government and private organizations in cancer research, and the rising demand for precision medicine, are anticipated to drive the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global AI In oncology market report, along with forecasts at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on component, cancer type, treatment type, and application.

Component Insights:

Software Solutions
Hardware
Services

The report has provided a detailed breakup and analysis of the AI In oncology market based on component. This includes software solutions, hardware, and services. According to the report, software solutions represented the largest segment.

Cancer Type Insights:

Breast Cancer
Lung Cancer
Prostate Cancer
Colorectal Cancer
Brain Tumor
Others

A detailed breakup and analysis of the AI In oncology market based on the cancer type has also been provided in the report. This includes breast cancer, lung cancer, prostate cancer, colorectal cancer, brain tumor, and others. According to the report, breast cancer accounted for the largest market share.

Treatment Type Insights:

Chemotherapy
Radiotherapy
Immunotherapy
Others

A detailed breakup and analysis of the AI In oncology market based on the treatment type has also been provided in the report. This includes chemotherapy, radiotherapy, immunotherapy, and others. According to the report, chemotherapy accounted for the largest market share.

Application Insights:

Cancer Detection
Drug Discovery
Drug Development
Others

A detailed breakup and analysis of the AI In oncology market based on the application has also been provided in the report. This includes cancer detection, drug discovery, drug development, and others.

Regional Insights:

North America
- United States
- Canada
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Others
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for AI In oncology. Some of the factors driving the North America AI in oncology market included growing incidences of cancer, supportive government policies, and significant technological advancements.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global AI In oncology market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Azra AI, ConcertAI (SymphonyAI LLC), Digital Diagnostics Inc., MEDIAN Technologies, Medtronic plc, PathAI Inc., Siemens Healthineers GmbH (Siemens AG), etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

AI In Oncology Market Report Scope:

Report Features	Details
Base Year of the Analysis	2024
Historical Period	2019-2024
Forecast Period	2025-2033
Units	Million USD
Scope of the Report	Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Predictive Market Assessment: · Component Cancer Type Treatment Type Application Region
Components Covered	Software Solutions, Hardware, Services
Cancer Types Covered	Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Brain Tumor, Others
Treatment Types Covered	Chemotherapy, Radiotherapy, Immunotherapy, Others
Applications Covered	Cancer Detection, Drug Discovery, Drug Development, Others
Regions Covered	North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Countries Covered	United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered	Azra AI, ConcertAI (SymphonyAI LLC), Digital Diagnostics Inc., MEDIAN Technologies, Medtronic plc, PathAI Inc., Siemens Healthineers GmbH (Siemens AG), etc.
Customization Scope	10% Free Customization
Post-Sale Analyst Support	10-12 Weeks
Delivery Format	PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

How has the global AI In oncology market performed so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the global AI In oncology market?
What is the impact of each driver, restraint, and opportunity on the global AI In oncology market?
What are the key regional markets?
Which countries represent the most attractive AI In oncology market?
What is the breakup of the market based on the component?
Which is the most attractive component in the AI In oncology market?
What is the breakup of the market based on the cancer type?
Which is the most attractive cancer type in the AI In oncology market?
What is the breakup of the market based on treatment type?
Which is the most attractive treatment type in the AI In oncology market?
What is the breakup of the market based on application?
Which is the most attractive application in the AI In oncology market?
What is the competitive structure of the global AI In oncology market?
Who are the key players/companies in the global AI In oncology market?

Key Benefits for Stakeholders:

IMARC’s report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the AI In oncology market from 2019-2033.
The research study provides the latest information on the market drivers, challenges, and opportunities in the global AI In oncology market.
The study maps the leading, as well as the fastest-growing, regional markets. It further enables stakeholders to identify the key country-level markets within each region.
Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the AI In oncology industry and its attractiveness.
Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.

Purchase Options New Year Sale

Inquire Before Buying

Speak to an Analyst

Request Brochure

Request Customization

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.